Strategies for Enhancing Mucosal Immunity to Influenza Vaccine.

Trial Profile

Strategies for Enhancing Mucosal Immunity to Influenza Vaccine.

Completed
Phase of Trial: Phase 0

Latest Information Update: 05 Dec 2012

At a glance

  • Drugs Influenza virus vaccine (Primary)
  • Indications Influenza virus infections
  • Focus Adverse reactions; Pharmacodynamics
  • Most Recent Events

    • 01 Aug 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 29 Jun 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top